Yolanda I. Garces
Papers
1
Total Citations
19
H-Index
1
About
Yolanda I. Garces is a leading radiation oncologist whose research focuses on optimizing treatment for head and neck cancers, particularly human papillomavirus-positive oropharyngeal cancer. Her major contributions center on de-escalation strategies to reduce long-term toxic effects while maintaining excellent cure rates. Her most-cited work, the MC1273 phase 2 study (19 citations), investigates decreasing adjuvant radiation and chemotherapy doses after transoral robotic surgery, reporting outcomes on long-term toxic effects, swallow function, and quality of life. This landmark study demonstrates her commitment to balancing oncologic efficacy with survivorship, addressing critical quality-of-life concerns for patients with highly curable HPV-positive disease. Garces’ research has significant clinical impact, providing evidence for less intensive treatment protocols that minimize debilitating side effects like dysphagia and xerostomia. Her work is instrumental in shaping modern de-escalation paradigms, offering patients curative therapy with reduced morbidity. Through rigorous clinical trials, Garces advances personalized, function-preserving approaches in radiation oncology, making her a pivotal figure in improving outcomes for head and neck cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1